In this section, the role of the NRF2 signaling pathway in various diseases, including diabetes, Alzheimer’s disease, kidney injury, and cancer, is discussed (Figure 2). This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.